For: | Madhusoodanan S, Ting MB. Pharmacological management of behavioral symptoms associated with dementia. World J Psychiatr 2014; 4(4): 72-79 [PMID: 25540722 DOI: 10.5498/wjp.v4.i4.72] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v4/i4/72.htm |
Number | Citing Articles |
1 |
Ana Hategan, James A. Bourgeois, Tracy Cheng, Julie Young. Geriatric Psychiatry Study Guide. 2018; : 269 doi: 10.1007/978-3-319-77128-1_11
|
2 |
Kim J. Curyto, Sue M. McCurry, Katherine Luci, Bradley E. Karlin, Linda Teri, Michele J. Karel. Managing Challenging Behaviors of Dementia in Veterans: Identifying and Changing Activators and Consequences Using STAR-VA. Journal of Gerontological Nursing 2017; 43(2): 33 doi: 10.3928/00989134-20160930-01
|
3 |
Yu-Yuan Huang, Teng Teng, Xue-Ning Shen, Shi-Dong Chen, Rong-Ze Wang, Rui-Qi Zhang, Kai-Xi Dou, Xiao-Ling Zhong, Jun Wang, Ke-Liang Chen, Qian-Hua Zhao, Lan Tan, Qiang Dong, Xin-Yu Zhou, Jin-Tai Yu. Pharmacological treatments for psychotic symptoms in dementia: A systematic review with pairwise and network meta-analysis. Ageing Research Reviews 2022; 75: 101568 doi: 10.1016/j.arr.2022.101568
|
4 |
Peihao Fan, Julia Kofler, Ying Ding, Michael Marks, Robert A Sweet, Lirong Wang. Efficacy difference of antipsychotics in Alzheimer’s disease and schizophrenia: explained with network efficiency and pathway analysis methods. Briefings in Bioinformatics 2022; 23(6) doi: 10.1093/bib/bbac394
|
5 |
Luisa Fernanda Ahunca Velásquez. Más allá del deterioro cognitivo: síntomas neuropsiquiátricos en demencias neurodegenerativas. Revista Colombiana de Psiquiatría 2017; 46: 51 doi: 10.1016/j.rcp.2017.05.006
|
6 |
H. Karl Greenblatt, David J. Greenblatt. Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia. The Journal of Clinical Pharmacology 2016; 56(9): 1048 doi: 10.1002/jcph.731
|
7 |
Marie Turmo Lornstad, Marte Aarøen, Sverre Bergh, Jūratė Šaltytė Benth, Anne-Sofie Helvik. Prevalence and persistent use of psychotropic drugs in older adults receiving domiciliary care at baseline. BMC Geriatrics 2019; 19(1) doi: 10.1186/s12877-019-1126-y
|
8 |
Eran Schmukler, Ronit Pinkas‐Kramarski. Autophagy induction in the treatment of Alzheimer's disease. Drug Development Research 2020; 81(2): 184 doi: 10.1002/ddr.21605
|
9 |
Haruhiko Sugino, Akihito Watanabe, Naoki Amada, Miho Yamamoto, Yuta Ohgi, Dusan Kostic, Raymond Sanchez. Global Trends in Alzheimer Disease Clinical Development: Increasing the Probability of Success. Clinical Therapeutics 2015; 37(8): 1632 doi: 10.1016/j.clinthera.2015.07.006
|
10 |
Sabrina D. Ross, Nadja Ziegert, Francisca S. Rodriguez. Identifying relevant psychosocial factors in the care of people with dementia: findings of a focus group study with health professionals and informal caregivers. Journal of Public Health 2023; doi: 10.1007/s10389-023-02093-y
|
11 |
Jennifer L. Sullivan, Jacquelyn Pendergast, Laura O. Wray, Omonyêlé L. Adjognon, Kimberly J. Curyto. Factors Related to Higher and Lower Performance and Adherence in STAR-VA Program Sustainment in Department of Veterans Affairs (VA) Community Living Centers (CLCs). Journal of the American Medical Directors Association 2024; 25(4): 711 doi: 10.1016/j.jamda.2023.11.011
|
12 |
Jana Martinková, Oľga Kabátová, Silvia Puteková. Influence of gender on the prevalence of behavioral symptoms in patients with Alzheimer's dementia. Kontakt 2019; 21(1): 74 doi: 10.32725/kont.2019.013
|
13 |
Jennifer Rose V. Molano, Robin Bratt, Rhonna Shatz. Treatment and Management of Dementia Due to Alzheimer’s Disease. Current Treatment Options in Neurology 2015; 17(8) doi: 10.1007/s11940-015-0363-4
|
14 |
Kazuyo Yoshiyama, Hideko Arita, Jinichi Suzuki. The Effect of Aroma Hand Massage Therapy for People with Dementia. The Journal of Alternative and Complementary Medicine 2015; 21(12): 759 doi: 10.1089/acm.2015.0158
|
15 |
L.H. Martín Arias, C. Treceño Lobato, S. Pérez García, P. García Ortega, M. Sáinz Gil, R. Sanz Fadrique, A. Carvajal García-Pando. Impact of regulatory measures on antipsychotics drug consumption in Castilla y León, Spain. Public Health 2016; 141: 113 doi: 10.1016/j.puhe.2016.08.011
|
16 |
Rajesh R. Tampi, Deena J. Tampi, Silpa Balachandran, Shilpa Srinivasan. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Therapeutic Advances in Chronic Disease 2016; 7(5): 229 doi: 10.1177/2040622316658463
|
17 |
Anne-Marie Di Passa, Melissa Dabir, Allan Fein, Saba Khoshroo, Carly McIntyre-Wood, Emma Marsden, Emily MacKillop, Jane De Jesus, James MacKillop, Dante Duarte. Clinical Efficacy of Deep Transcranial Magnetic Stimulation in Psychiatric and Cognitive Disorders: Protocol for a Systematic Review. JMIR Research Protocols 2023; 12: e45213 doi: 10.2196/45213
|
18 |
Gillian Hamilton, Barbara E. Volk-Craft. A Model Hospice Inpatient Unit Specializing in Patients Living with Advanced Dementia. Journal of Palliative Medicine 2021; 24(4): 589 doi: 10.1089/jpm.2020.0436
|
19 |
Madison Stanley, Nicolas Poupore, Krista Knisely, Alyssa Miller, Adebobola Imeh-Nathaniel, Laurie Theriot Roley, Samuel Imeh-Nathaniel, Rich Goodwin, Thomas I. Nathaniel. Differences in pharmacologic and demographic factors in male and female patients with vascular dementia, Alzheimer's disease, and mixed vascular dementia. Frontiers in Dementia 2023; 2 doi: 10.3389/frdem.2023.1137856
|
20 |
Sabrina D. Ross, Nadja Ziegert, Francisca S. Rodriguez. Implementation of Non-pharmacological Interventions in Dementia Care: Family Caregiver Perspective. Home Health Care Management & Practice 2024; 36(1): 20 doi: 10.1177/10848223231174226
|
21 |
Rezaul Karim Khandker, Farid Chekani, Kirti Mirchandani, Niranjan Kathe. Diagnosis of behavioral symptoms as a predictor of institutionalization among Medicaid patients with dementia. BMC Geriatrics 2023; 23(1) doi: 10.1186/s12877-023-04506-9
|
22 |
Maaz Ahmed Khan, Varsha Srivastava, Mariya Kabir, Monalisha Samal, Areeba Insaf, Mohammad Ibrahim, Sultan Zahiruddin, Sayeed Ahmad. Development of Synergy-Based Combination for Learning and Memory Using in vitro, in vivo and TLC-MS-Bioautographic Studies. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.678611
|
23 |
Safoura Sheikh Rezaei, Stefan Weisshaar, Brigitte Litschauer, Ghazaleh Gouya, Gerald Ohrenberger, Michael Wolzt. ADMA and NT pro‐BNP are associated with overall mortality in elderly. European Journal of Clinical Investigation 2019; 49(1) doi: 10.1111/eci.13041
|
24 |
Koji Fukuda, Seishi Terada, Mamoru Hashimoto, Katsuyuki Ukai, Ryo Kumagai, Mizue Suzuki, Masahiro Nagaya, Mika Yoshida, Hideyuki Hattori, Kenta Murotani, Kenji Toba. Effectiveness of educational program using printed educational material on care burden distress among staff of residential aged care facilities without medical specialists and/or registered nurses: Cluster quasi‐randomization study. Geriatrics & Gerontology International 2018; 18(3): 487 doi: 10.1111/ggi.13207
|
25 |
Joanna Sikora, Maria Podsiedlik, Tadeusz Pietras, Marcin Kosmalski, Mikołaj Matłoka, Rafał Moszczyński-Petkowski, Maciej Wieczorek, Magdalena Markowicz-Piasecka. Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil. Journal of Enzyme Inhibition and Medicinal Chemistry 2020; 35(1): 1743 doi: 10.1080/14756366.2020.1818739
|
26 |
Sagar Karia, Avinash Desousa, Nilesh Shah. A retrospective chart analysis of 34 cases with the use of oral cerebroprotein hydrolysate in dementia in a tertiary general hospital. Journal of Geriatric Mental Health 2021; 8(1): 30 doi: 10.4103/jgmh.jgmh_10_20
|
27 |
John Shadarevian, Cheryl Chan, Annette Berndt, Cathy Son, Mario Gregorio, Neil Horne, Jim Mann, Christine Wallsworth, Bryan Chow, Ryan O’Neill, Lillian Hung. Creating a toolkit with stakeholders for leveraging tablet computers to support person-centred dementia care in hospitals. Journal of Rehabilitation and Assistive Technologies Engineering 2020; 7 doi: 10.1177/2055668320960385
|
28 |
Radoslaw Magierski, Tomasz Sobow. Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia. Expert Review of Neurotherapeutics 2016; 16(4): 375 doi: 10.1586/14737175.2016.1155453
|
29 |
Radoslaw Magierski, Tomasz Sobow. Benefits and Risks of Add-On Therapies for Alzheimer’s Disease. Neurodegenerative Disease Management 2015; 5(5): 445 doi: 10.2217/nmt.15.39
|
30 |
Chih-Hsiang Hsu, Sheue-Er Wang, Ching-Lung Lin, Chun-Jen Hsiao, Shuenn-Jyi Sheu, Chung-Hsin Wu, Jian-Li Gao. Neuroprotective Effects of the Herbal Formula B401 in Both Cell and Mouse Models of Alzheimer’s Disease. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/1939052
|
31 |
Prabhat Upadhyay, Sunil K. Mishra, Suresh Purohit, G. P. Dubey, Brijesh Singh Chauhan, S. Srikrishna. Antioxidant, antimicrobial and cytotoxic potential of silver nanoparticles synthesized using flavonoid rich alcoholic leaves extract of Reinwardtia indica. Drug and Chemical Toxicology 2019; 42(1): 65 doi: 10.1080/01480545.2018.1488859
|
32 |
Anne-Marie Di Passa, Shelby Prokop-Millar, Horodjei Yaya, Melissa Dabir, Carly McIntyre-Wood, Allan Fein, Emily MacKillop, James MacKillop, Dante Duarte. Clinical efficacy of deep transcranial magnetic stimulation (dTMS) in psychiatric and cognitive disorders: A systematic review. Journal of Psychiatric Research 2024; 175: 287 doi: 10.1016/j.jpsychires.2024.05.011
|
33 |
Lena M. Hofbauer, Sabrina D. Ross, Francisca S. Rodriguez. Music‐basedinterventions forcommunity‐dwellingpeople with dementia: A systematic review. Health & Social Care in the Community 2022; 30(6): 2186 doi: 10.1111/hsc.13895
|
34 |
Haewon Byeon. Predicting the Severity of Parkinson’s Disease Dementia by Assessing the Neuropsychiatric Symptoms with an SVM Regression Model. International Journal of Environmental Research and Public Health 2021; 18(5): 2551 doi: 10.3390/ijerph18052551
|
35 |
Kevin W. McConeghy, Kim Curyto, Jenefer Jedele, Orna Intrator, David C. Mohr, Ilse R. Wiechers, Michele J. Karel. Impact of an interdisciplinary intervention for distress behaviors in dementia on psychotropic drug use in Veterans Health Administration Community Living Centers. Geriatric Nursing 2021; 42(6): 1533 doi: 10.1016/j.gerinurse.2021.10.009
|
36 |
Daniel R. Bateman, Sascha Gill, Sophie Hu, Erin D. Foster, Myuri T. Ruthirakuhan, Allis F. Sellek, Moyra E. Mortby, Veronika Matušková, Kok Pin Ng, Rawan M. Tarawneh, Yvonne Freund‐Levi, Sanjeev Kumar, Serge Gauthier, Paul B. Rosenberg, Fabricio Ferreira de Oliveira, D. P. Devanand, Clive Ballard, Zahinoor Ismail. Agitation and impulsivity in mid and late life as possible risk markers for incident dementia. Alzheimer's & Dementia: Translational Research & Clinical Interventions 2020; 6(1) doi: 10.1002/trc2.12016
|
37 |
Michele Torrisi, Maria C. De Cola, Angela Marra, Rosaria De Luca, Placido Bramanti, Rocco S. Calabrò. Neuropsychiatric symptoms in dementia may predict caregiver burden: a Sicilian exploratory study. Psychogeriatrics 2017; 17(2): 103 doi: 10.1111/psyg.12197
|
38 |
Prabhat Upadhyay, Ananya Sadhu, Praveen K. Singh, Aruna Agrawal, K. Ilango, Suresh Purohit, Govind Prasad Dubey. Revalidation of the neuroprotective effects of a United States patented polyherbal formulation on scopolamine induced learning and memory impairment in rats. Biomedicine & Pharmacotherapy 2018; 97: 1046 doi: 10.1016/j.biopha.2017.11.008
|